Fenfluramine Synthesis Using Hydrosilane Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for preparing fenfluramine suffer from impurity generation, the use of flammable hydrogen gas or metal hydride reducing agents, and toxic organic solvents, making them unsuitable for commercial-scale production.
Innovation Solution
A process involving the reaction of 3-(trifluoromethyl)phenylacetone with ethylamine in the presence of a heterogeneous light platinum-group metal catalyst, such as palladium on carbon, and a hydrosilane, conducted in an aqueous mixture with a surfactant, which avoids the use of reactive metal hydrides and organic solvents, and is scalable for commercial production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If existing processes use metal hydride reducing agents or hydrogen gas, then fenfluramine can be produced, but flammable and hazardous reducing agents are required
Solution Approach 1:
The patent changes the chemical nature of the reducing agent from reactive metal hydrides or hydrogen gas to organosilane compounds, which are less hazardous and flammable. This parameter change in the reducing agent type maintains production capability while improving safety and reducing harmful factors.
Solution Approach 2:
The patent employs organosilane reducing agents that can be used in stoichiometric amounts and do not require special handling infrastructure. These reagents are consumed in the reaction and replaced, avoiding the need for expensive and complex hydrogen gas handling systems or metal hydride storage facilities.
2Ease of manufacture
If existing processes use toxic organic solvents, then fenfluramine can be produced, but toxic solvents are required
Solution Approach 1:
The patent changes the solvent system from toxic organic solvents to water as the primary solvent. This parameter change eliminates toxicity concerns while maintaining the reaction capability through the use of surfactants and phase transfer catalysts that enable the reaction in aqueous media.
Solution Approach 2:
The patent introduces surfactants and phase transfer catalysts as intermediaries that enable the reaction between organic substrates and aqueous reagents. These intermediaries allow the reaction to proceed in water without requiring toxic organic solvents, bridging the compatibility gap between organic and aqueous phases.
3Productivity
If existing processes are used, then fenfluramine can be produced, but impurities are generated requiring additional purification
Solution Approach 1:
The patent changes the reaction conditions and reagent types to achieve higher selectivity. The use of organosilane reducing agents and optimized catalytic systems reduces side reactions and impurity formation, thereby improving product purity while maintaining production efficiency.
Solution Approach 2:
The patent employs controlled reaction conditions and catalytic systems that minimize impurity formation through selective reaction pathways. The process design incorporates parameters that favor the desired product formation while suppressing side reactions, reducing the need for extensive purification steps.
4Productivity
If existing processes are used, then fenfluramine can be produced, but the processes are not suitable for commercial-scale production
Solution Approach 1:
The patent changes the overall process parameters to use commercially viable reagents and conditions. The substitution of hazardous reducing agents with organosilanes and toxic solvents with water makes the process suitable for commercial-scale production by eliminating special handling requirements while maintaining productivity.
Solution Approach 2:
The patent employs reagents and solvents that are commercially available, stable, and do not require specialized storage or handling infrastructure. This enables straightforward scaling to commercial production without the complex safety infrastructure needed for metal hydrides or hydrogen gas.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method produces fenfluramine with high purity, reducing impurities like 1-[3-(trifluoromethyl)phenyl]-2-propanol to less than 0.2 area % and minimizing catalyst metal impurities, enabling efficient and safe commercial-scale production.
Implementation Method 1
reacting 3-(trifluoromethyl)phenylacetone with ethylamine, or a salt thereof, in the presence of an aqueous mixture comprising a heterogenous light platinum-group metal catalyst
Implementation Method 2
reacting 3-(trifluoromethyl)phenylacetone with ethylamine, or a salt thereof, in the presence of an aqueous mixture comprising a heterogenous light platinum-group metal catalyst, and a hydrosilane
Implementation Method 3
conducted in an aqueous mixture with a surfactant
Data Source
AI summary
The present invention provides processes for the preparation of fenfluramine and salts thereof, including reductive amination of 3-(trifluoromethyl) phenylacetone, as well as products prepared by such processes.